IFNGR1, along with type I IFN receptors, which were also upregulated in our study, may be of particular interest in IC/BPS since they are considered to be pivotal players in various inflammatory and autoimmune diseases (69, 70). This evidence concerns the gene IFNGR1 and Bartsocas-Papas syndrome 1.